The ISMRC meetings were initiated almost 25 years ago in 1996 by Klaus Pantel, and, represent now a major event in the world related to many aspects of Liquid Biopsy in cancer patients.

This international meeting is a fantastic opportunity to gather for three days and share many updated aspects concerning the use of liquid biopsies in cancer patients. Moreover, this meeting covers many new developments of liquid biopsy for clinical implementation, with some specific focuses on the role of liquid biopsy in treatment decision making both for immuno-oncology and targeted therapies. Moreover, special sessions will be dedicated to the new aspects of minimal residual disease detection, early detection and screening cancers, and monitoring disease by blood sampling for tracking resistance mechanisms to different therapeutic.

The congress will include also more fundamental and translational presentations on different liquid biopsy components (Circulating Tumor Cells, exosomes, miRNA and circulating free DNA). Additionnally the perspective of liquid biopsy for the next few years will be presented. The 2025 meeting in Nice is supported by the European Liquid Biopsy Society (ELBS) and the new Institut RespirERA created in Nice (IHU RespirERA).

Plenary presentations will be given by leading international experts in different fields of liquid biopsy, as well as in cancer biology. Moreover, the ISMRC strongly supports young investigators through selected oral communications as part of plenary sessions but also poster presentations. Importantly, outstanding oral and poster presentations will be awarded with our Young investigator awards.